Obtaining a Waiver to Prescribe Buprenorphine

How To Submit Your Waiver Form - It's Easy!

Providers who have completed buprenorphine training must next submit an online from, the Notification of Intent form (AKA "waiver form/SMA-167/NOI"), to the Center for Substance Abuse Treatment (CSAT), via SAMHSA's website, before they start prescribing.

  1. Submit the online Buprenorphine Waiver Notification form. You must submit this form if you plan on prescribing buprenorphine. Visit SAMHSA's webpage SAMHSA Buprenorphine Waiver Management" page to get the latest information.
  2. Allow 45 days for CSAT to review your waiver notification form. Note that we send notification of your completion of the training to them within around a week of your completion. After your waiver notification has been reviewed, you will receive a prescribing identification number ("X" number) from the DEA via email. You will need to write this number on all buprenorphine prescriptions that you write. Your regular DEA number will not change. NPs and PAs who prescribe buprenorphine will also be issued a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number. 
  3. If you have not heard from CSAT after 45 days, you may begin prescribing. However, if you do not receive your X number within 60 days, contact CSAT:

Note that providers who have completed buprenorphine training can immediately treat one patient emergently but must wait until getting their prescribing identification number before taking a caseload of patients.

Related Resources: 
Description: 
Find information for providers on the waiver application and management process to prescribe or dispense buprenorphine for opioid dependency treatment.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
field_vote: 
Physician stage in practice: 
Description: 
This page provides links to the full text, summary, and physician waiver requirements under DATA 2000.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
field_vote: 
Physician stage in practice: 
Description: 
This webpage provides answers to frequently asked questions from physicians about buprenorphine and the Drug Addiction Treatment Act of 2000 (DATA 2000).
Source: 
CSAT Buprenorphine Information Center
field_vote: 
Tags: